News
Important Only
S&W Seed Co expected to post a loss of $1.09 a share - Earnings Preview
S&W Seed Co SANW.OQ SANW.O is expected to show a fall in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025The Longmont Colorado-based company is expected to report a 48.2% decrease in revenue to $9.5 million from $18.32 million a year ago, acco...Reuters
Fri, May 9
Palisade Bio Inc expected to post a loss of 70 cents a share - Earnings Preview
Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Palisade Bio Inc is for a loss of 70 cents per share. The current average analyst rating on the s...Reuters
Fri, May 9
Ceasefire efforts in Ukraine moving in right direction, Finland says
By Gwladys Fouche OSLO, May 9 (Reuters) - Efforts towards securing an agreed ceasefire in Ukraine are moving in the right direction, Finnish President Alexander Stubb said on Friday, shortly after speaking with Ukraine's President Volodymyr Zelenskiy and U.S. President Donald Trump. Finland&#...Reuters
Fri, May 9
Pyxis Oncology Inc expected to post a loss of 29 cents a share - Earnings Preview
Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show a fall in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Pyxis Oncology Inc is for a loss of 29 cents per share. The current average analyst rating on the ...Reuters
Fri, May 9
Atossa Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview
Atossa Therapeutics Inc ATOS.OQ ATOS.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Atossa Therapeutics Inc is for a loss of 6 cents per share. The current average analyst ra...Reuters
Fri, May 9
Quince Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Quince Therapeutics Inc QNCX.OQ QNCX.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Quince Therapeutics Inc is for a loss of 23 cents per share. The current average analyst r...Reuters
Fri, May 9
Flowco Holdings Inc expected to post earnings of 32 cents a share - Earnings Preview
Flowco Holdings Inc FLOC.N, FLOC.K is expected to report resultson May 13 for the period ending March 31 2025The Houston Texas-based company is expected to report revenue of $198.83 million, according to the mean estimate from 8 analysts, based on LSEG data.LSEG's mean analyst estimate for Flo...Reuters
Fri, May 9
Athletics-Hurdles queen McLaughlin-Levrone to run first professional 100m flat at Grand Slam
NEW YORK, May 9 (Reuters) - American Sydney McLaughlin-Levrone will run her first professional 100 metres race at the Philadelphia Grand Slam Track meet that begins later this month, the athletics circuit said on Friday.The 400m hurdles world record holder and twice Olympic champion has kept a stran...Reuters
Fri, May 9
FedEx board member tapped to lead U.S. Postal Service
WASHINGTON, May 9 (Reuters) - The U.S. Postal Service Board on Friday said they have named FedEx board member and former CEO of Waste Management, as the new postmaster general after the White House pressured the prior leader to resign in March.Postal unions have raised sharp concerns about the selec...Reuters
Fri, May 9
Heritage adds $285 million of limit as it renews cat XoL program
By Chris MunroMay 9 - (The Insurer) - Heritage Insurance Holdings will enter the North Atlantic hurricane season with its insurance subsidiaries backed by a 2025/26 catastrophe excess of loss (XoL) reinsurance program that has had its limit increased by $285 million to $2.479 billion.In an update is...Reuters
Fri, May 9
Abeona Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Abeona Therapeutics Inc ABEO.OQ ABEO.O is expected to show no change in quarterly revenue when it reports results on May 13 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Abeona Therapeutics Inc is for a loss of 36 cents per share. The current average analyst r...Reuters
Fri, May 9
VerifyMe Inc expected to post a loss of 7 cents a share - Earnings Preview
VerifyMe Inc VRME.OQ VRME.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025The Lake Mary Florida-based company is expected to report a 11.6% decrease in revenue to $5.092 million from $5.76 million a year ago, according to the m...Reuters
Fri, May 9
J&J's oral psoriasis drug helps patients achieve clear skin in late-stage study
May 9 (Reuters) - Johnson & Johnson JNJ.N said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily pill helped patients achieve clear or almost clear skin.The drugmaker has been working on more convenient treatment options as its injectable psoria...Reuters
Fri, May 9
Bund yields rise to multi-week highs on trade hopes
UK-US trade deal spurs optimism for tariff de-escalationUS-Chinese officials to hold talks this weekendEuro zone growth environment worsening - Finnish central bankerBy Stefano Rebaudo May 9 (Reuters) - German Bund prices fell on Friday, pushing yields higher, as investors moved away from safe-ha...Reuters
Fri, May 9
Fennec Pharmaceuticals Inc expected to post a loss of 9 cents a share - Earnings Preview
Fennec Pharmaceuticals Inc FENC.OQ FENC.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025The Research Triangle Park North Carolina-based company is expected to report a 67.8% decrease in revenue to $8.181 million from $25.38 mil...Reuters
Fri, May 9
Edible Garden AG Inc expected to post a loss of $3.03 a share - Earnings Preview
Edible Garden AG Inc EDBL.OQ EDBL.O is expected to show a rise in quarterly revenue when it reports results on May 15 for the period ending March 31 2025The Belvidere New Jersey-based company is expected to report a 22.0% increase in revenue to $3.821 million from $3.13 million a year ago, accordi...Reuters
Fri, May 9
Jasper Therapeutics Inc expected to post a loss of $1.31 a share - Earnings Preview
Jasper Therapeutics Inc JSPR.OQ JSPR.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Jasper Therapeutics Inc is for a loss of $1.31 per share. The current average analyst rati...Reuters
Fri, May 9
Y-mAbs Therapeutics Inc expected to post a loss of 21 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc YMAB.OQ YMAB.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025The Princeton New Jersey-based company is expected to report a 1.6% decrease in revenue to $19.605 million from $19.93 million a year ago, acc...Reuters
Fri, May 9
